Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma

Journal of Immunology

Volumn 162, Issue 7, 1999, Pages 4212-4219

  Kumagai, Katsunori ^a   Ohno, Isao ^a   Okada, Shinji ^a   Ohkawara, Yuichi ^a   Suzuki, Ko ^b   Shinya, Takashi ^c   Nagase, Hideaki ^d   Iwata, Kazushi ^c   Shirato, Kunio ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Miyagi Red Cross Blood Center   (Japan)

^c FUJI CHEMICAL INDUSTRIES LTD   (Japan)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; MATRIX METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CELL MIGRATION; CONTROLLED STUDY; ENZYME INHIBITION; EOSINOPHIL; FEMALE; INFLAMMATORY CELL; LEUKOCYTE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; T LYMPHOCYTE;

ADMINISTRATION, INHALATION; ALLERGENS; ANIMALS; ANTIGENS, CD3; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; COLLAGENASES; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; GELATINASES; HUMANS; INFLAMMATION; INTERLEUKIN-5; LEUKOCYTE COUNT; LUNG; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MICE; MICE, INBRED BALB C; OVALBUMIN; PROTEIN BINDING; RECOMBINANT PROTEINS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRACHEA;

EID: 0033120966     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Jonathan, P. A., and T. H. Lee. 1992. The pathobiology of bronchial asthma. Adv. Immunol. 51:323.
2. Bousquet, J., P. Chanez, J. Y. Lacoste, G. Barneon, N. Ghavanian, I. Enander, P. Venge, S. Ahlstedt, J. S. Lafontaine, P. Godard, and F.-B. Michel. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323:1033.
3. Kay, A. B. 1991. Asthma and inflammation. J. Allergy Clin. Immunol. 87:893.
4. Busse, W. W., F. C. William, and J. D. Sedgwick. 1993. Mechanism of airway inflammation in asthma. Am. Rev. Respir. Dis. 147:S20.
5. Catherine, H. S., J. N. W. N. Barker, and T. H. Lee. 1993. Adhesion molecules in allergic inflammation. Am. Rev. Respir. Dis. 148:S75.
6. Resnik, M. B., and P. F. Weller. 1993. Mechanism of eosinophil recruitment. Am. J. Respir. Cell Mol. Biol. 8:349.
7. Teran, L. M., and D. E. Davies. 1996. The chemokines: their potential role in allergic inflammation. Clin. Exp. Allergy 26:1005.
8. Yurchenco, P. D., and J. O'Rear. 1995. Supramolecular organization of basement membranes. In Molecular and Cellular Aspects of Basement Membranes. D. H. Rohrbach and R. Timpl. eds. Academic Press, New York, p. 19.
9. Nagase, H. 1997. Activation mechanisms of matrix metalloproteinases. Biol. Chem. 378:151.
10. Murphy, G., and A. J. P. Docherty. 1992. The matrix metalloproteinases and their inhibitors. Am. J. Respir. Cell Mol. Biol. 7:120.
11. Yao, P. M., B. Maitre, C. Delacourt, J. M. Buhler, A. Harf, and C. Lafuma. 1997. Divergent regulation of 92-kDa gelatinase and TIMP-1 by HBECs in response to IL-1β and TNF-α. Am. J. Physiol. 273:L866.
12. Mautino, G., N. Oliver, P. Chanez, J. Bousquet, and F. Capony. 1997. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthamatics. Am. J. Respir. Cell Mol. Biol. 17:583.
13. Leppert, D., E. Waubant, R. Galardy, N. W. Bunnett, and S. L. Hauser. 1995. T cell gelatinases mediate basement membrane transmigration in vitro. J. Immunol. 154:4379.
14. Delcaux, C., C. Delacourt, M.-P. d'Ortho, V. Boyer, C. Lafuma, and A. Harf. 1996. Role of gelatinase B and elastase in human polymorphonuclear neutrohil migration across basement membrane. Am. J. Respir. Cell Mol. Biol. 14:288.
15. Stahle-Backdahl, M., M. Inoue, G. J. Guidice, and W. C. Parks. 1994. 92-kDa type IV collagenase mRNA by eosinophils associated with basal cell carcinoma. J. Invest. Dermatol. 99:497.
16. O'Connor, C. M., and M. X. FitzGerald. 1994. Matrix metalloproteases and lung disease. Thorax 49:602.
17. Tetley, T. D. 1993. Proteinase imbalance: its role in lung disease. Thorax 48:560.
18. Liotta, L. A., K. Tryggvason, S. Garvisa, I. Hart, C. M. Foltz, and S. Shafie. 1980. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284:67.
19. Okada, S., H. Kita, T. J. George, G. J. Gleich, and K. M. Leiferman. 1997. Migration of eosinophil through basement membrane components in vitro: role of matrix metalloproteinase-9. Am. J. Respir. Cell Mol. Biol. 17:519.
20. Ohno, I., H. Ohtani, Y. Nitta, J. Suzuki, H. Hosi, M. Honma, S. Isoyama, Y. Tanno, G. Tamura, K. Yamauchi, H. Nagura, and K. Shirato. 1997. Eosinophil as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am. J. Respir. Cell Mol. Biol. 16:212.
21. Ohkawara, Y., X.-F. Lei, M. R. Stampfli, J. S. Marshall, Z. Xing, and M. Jordana. 1997. Cytokine and eosinophil responses in the lung, peripheral blood and bone marrow compartments in a murine model of allergen-induced airway inflammation. Am. J. Respir. Cell Mol. Biol. 16:510.
22. Tamaki, K., K. Tanzawa, S. Kurihara, T. Oikawa, S. Monma, K. Shimada, and Y. Sugimura. 1995. Synthesis and structure-activity relationships of gelatinase inhibitors derived from matlystains. Chem. Pharm. Bull. 43:1883.
23. Heussen, C., and E. B. Dowdle. 1980. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 102:196.
24. Fujimoto, N., J. Zhang, K. Iwata, T. Shinya, Y. Okada, and T. Hayakawa. 1993. A one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases-2 using monoclonal antibodies. Clin. Chim. Acta. 220:31.
25. Thrailkill, K. M., L. D. Quarles, H. Nagase, K. Suzuki, D. M. Serra, and J. L. Fowlkes. 1995. Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation. Endocrinology 136:3527.
26. Mead, J., and J. L. Whittenberger. 1953. Physical properties of human lungs measured during spontaneous respiration. J. Appl. Physiol. 5:779.
27. Tanaka, H., K. Hojo, H. Yoshida, T. Yoshioka, and K. Sugita. 1993. Molecular cloning and expression of the mouse 105-kDa gelatinase cDNA. Biochem. Biophys. Res. Commun. 190:732.
28. Ito, T., T. Ikeda, H. Gomi, S. Nakano, T. Suzuki, and S. Itohara. 1997. Unaltered secretion of β-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J. Biol. Chem. 272:22389.
29. Warner, J. A., P. Julius, W. Luttmann, and C. Kroegel. 1997. Matrix metalloproteinases in bronchoalveolar lavage fluid following antigen challenge. Int. Arch. Allergy Immunol. 113:318.
30. Shah, A., M. K. Church, and S. T. Holgate. 1995. Tumor necrosis factor α: a potential mediator of asthma. Clin. Exp. Allergy 25:1038.
31. Broide, D. H., M. Lotz, A. J. Cuomo, D. A. Coburn, E. C. Federman, and S. I. Wasserman. 1992. Cytokines in symptomatic asthma airways. J. Allergy Clin, Immunol. 89:958.
32. Herbert, C. A., M. J. Arthur, and C. Robinson. 1996. Augmentation by eosinophils of gelatinase activity in the airway mucosa: comparative effects as a putative mediator of epithelial injury. Br. J. Pharmacol. 117:667.
33. Ying, S., S. R. Durham, C. I. Corrigan, Q. Hamid, and A. B. Kay. 1995. Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon γ) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am. J. Respir. Cell Mol. Biol. 12:477.
34. Hamelmann, E., A. Oshiba, J. Loader, G. L. Larsen, G. Gleich, J. Lee, and E. W. Gelfand. 1997. Antiinterleukin-5 antibody prevents airway hyperreponsiveness in a murine model of airway sensitization. Am. J. Respir. Crit. Care Med. 155:819.
35. Foster, P. S., S. P. Hogan, A. J. Ramsay, K. I. Matthaei, and I. G. Young. 1996. Interleukin 5 deficiency abolishes cosinophilia, airway hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:1.
36. Broide, D. H., M. M. Paine, and G. S. Firestein. 1992. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J. Clin. Invest. 90:1414.
37. Bradding, P., J. A. Roberts, K. M. Britten, S. Montefort, R. Djukanovic, R. Mueller, C. H. Heusser, P. H. Howarth, and S. T. Holgate. 1994. Interleukin-4, -5, and -6 and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am. J. Respir. Cell Mol. Biol. 10:471.
38. Gleich, G. J. 1990. The eosinophil and bronchial asthma: current understanding. J. Allergy Clin. Immunol. 85:422.
39. De Sanctis, G. T., A. Itoh, F. H. Green, S. Quin, T. Kimura, J. K. Grobholz, T. R. Martin, T. Maki, and J. M. Drazen. 1997. T-lymphocytes regulate genetically determined airway hyperresponsiveness in mice. Nat. Med. 3:460.
40. Yasui, S., A. Nagai, K. Aoshiba, Y. Ozawa, Y. Kakuta, and K. Konno. 1995. A specific neutrophil elastase inhibitor (ONO-5046. Na) attenuates LPS-induced acute lung inflammation in the hamster Eur. Respir. J. 8:1293.